EpiVax Re-Pledges Commitment to Improving [Human] Health Everywhere
Providence, R.I., December 28th, 2018
EpiVax, Inc. is once more pledging to fulfill its mission to “improve human health everywhere”. The employees of this Providence-based, privately-owned biotechnology company are constantly achieving this fundamental through their day-to-day scientific work and continuous support for non-profit organizations.
Each year, a portion of EpiVax’s net revenue is allocated to charitable foundations, with a focus on local community organizations near the company HQ. Local not-for-profits that receive donations from EpiVax include the GAIA Vaccine Foundation (http://www.gaiavaccine.org/), Clínica Esperanza/Hope Clinic (www.aplacetobehealthy.com), and the Woonasquatucket River Watershed Council, all of which are located in Olneyville, Rhode Island (also home to EpiVax HQ).
In addition to providing monetary contributions to non-profit organizations, EpiVax promotes volunteerism among its employees. The VaxGivesBack committee at EpiVax is comprised of employees who volunteer their time to participate in activities and programming that assist non-profits. EpiVax employees also volunteer at local organizations. A recent company poll found that more than half of all EpiVax Employees had volunteered in 2018. Our CEO serves as volunteer medical director at Clinica Esperanza/Hope Clinic, for example, and our HR manager serves on the board of GAIA Vaccine Foundation.
EpiVax is a 20-year old privately-held biotechnology company located in Providence, RI, with a broad portfolio of projects including vaccines and immunotherapies for infectious diseases, autoimmunity and cancer. Scientists at EpiVax, led by co-founders Annie De Groot, MD and Bill Martin, lead the field in immunogenicity risk assessment. The ISPRI and iVAX toolkits for therapeutics and vaccines are used by a global roster of companies.